已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Could the PARIS Risk Scores Be Useful for the Choice of Triple versus Dual Antithrombotic Therapy in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention?

抗血栓 医学 传统PCI 经皮冠状动脉介入治疗 心房颤动 内科学 心脏病学 观察研究 心肌梗塞
作者
Leonardo De Luca,Leonardo Bolognese,Andrea Rubboli,Donata Lucci,Domenico Gabrielli,Furio Colivicchi,Michele Massimo Gulizia
出处
期刊:Cardiology [Karger Publishers]
卷期号:147 (2): 133-136 被引量:3
标识
DOI:10.1159/000521673
摘要

Introduction: Current guidelines recommend dual antithrombotic therapy (DAT) for the majority of patients with atrial fibrillation (AF) undergoing percutaneous coronary intervention (PCI) and suggest a short course of triple antithrombotic therapy (TAT) for those at very high thrombotic risk (TR) but low bleeding risk (BR). Methods: We analyze if the PARIS ischemic-hemorrhagic scale could be useful for the choice of antithrombotic strategy in patients with acute coronary syndromes and AF treated with coronary stenting enrolled in the prospective, observational, nationwide MATADOR-PCI study. Results: Among the 588 patients discharged alive, a TAT was prescribed in 381 (64.8%) and DAT in 52 (8.8%) patients. According to the PARIS scoring system, 142 (24.2%) were classified as low, 244 (41.5%) as intermediate, and 292 (34.3%) as high TR. In parallel, 87 (14.8%) were categorized in the low, 260 (44.2%) in the intermediate, and 241 (41.0%) in the high-risk stratum for major bleedings. Crossing the various strata of the two PARIS risk scores, the largest group of patients consisted of those at high TR and BR (n = 130, 22%), followed by those at intermediate risk according to both scores (n = 122, 21%). At discharge, TAT was mainly used in patients at intermediate to high BR, while DAT in those at intermediate to high TR but low BR, according to the PARIS score. Conclusion: Our data suggest that some variables associated with increased TR or BR are poorly considered in the daily practice, while the use of PARIS scales could help in the implementation of guidelines’ recommendations.

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
直觉发布了新的文献求助10
2秒前
5秒前
5秒前
领导范儿应助桀桀桀采纳,获得10
5秒前
6秒前
7秒前
小燕子完成签到,获得积分10
9秒前
loong发布了新的文献求助10
11秒前
hhllhh发布了新的文献求助10
11秒前
畅快芾发布了新的文献求助30
12秒前
安生完成签到,获得积分10
12秒前
周思齐完成签到 ,获得积分20
13秒前
如果发布了新的文献求助10
14秒前
CodeCraft应助loong采纳,获得10
16秒前
FashionBoy应助七爷采纳,获得10
17秒前
浮生若梦完成签到,获得积分10
19秒前
粒er完成签到 ,获得积分10
19秒前
科研通AI2S应助zhao采纳,获得10
20秒前
omgggg完成签到,获得积分10
21秒前
25秒前
丘比特应助虚影采纳,获得10
32秒前
头发茂密的我完成签到,获得积分10
32秒前
32秒前
32秒前
桀桀桀发布了新的文献求助10
36秒前
36秒前
赘婿应助Arui采纳,获得10
37秒前
40秒前
小羊发布了新的文献求助10
41秒前
斯文的萧关注了科研通微信公众号
42秒前
43秒前
44秒前
honeylaker完成签到,获得积分10
46秒前
111111111发布了新的文献求助10
46秒前
46秒前
云澈完成签到,获得积分10
48秒前
Arui发布了新的文献求助10
49秒前
51秒前
54秒前
呜呜完成签到 ,获得积分10
55秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
Aktuelle Entwicklungen in der linguistischen Forschung 300
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3989868
求助须知:如何正确求助?哪些是违规求助? 3531994
关于积分的说明 11255752
捐赠科研通 3270793
什么是DOI,文献DOI怎么找? 1805053
邀请新用户注册赠送积分活动 882215
科研通“疑难数据库(出版商)”最低求助积分说明 809208